Clinical Trial: A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomized Comparison of Two Dosage Schedules of Intravitreal ISIS 2922 for Patients With Advanced Cytomegalovirus Retinitis
Brief Summary: The purpose of this study is to compare the safety and effectiveness of two dosage schedules for ISIS 2922 in the treatment of advanced cytomegalovirus (CMV) retinitis
Detailed Summary: This is a multicenter, prospective, randomized, open-label study comparing 2 dosage schedules of ISIS 2922.
Sponsor: Ionis Pharmaceuticals, Inc.
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: NIH AIDS Clinical Trials Information Service
Dates:
Date Received: November 2, 1999
Date Started:
Date Completion:
Last Updated: June 23, 2005
Last Verified: December 1998